Dual chamber pacing system and method with continual adjustment of the
AV escape interval so as to maintain optimized ventricular pacing for
treating cardiomyopathy
    21.
    发明授权
    Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy 失效
    双室起搏系统和方法,连续调整AV逃逸间隔,以保持优化的心室起搏治疗心肌病

    公开(公告)号:US5626620A

    公开(公告)日:1997-05-06

    申请号:US391883

    申请日:1995-02-21

    摘要: A dual chamber pacemaker is provided having capability for adjusting the AV escape interval so as to optimize the timing of delivered ventricular pace pulses for therapy of patients with cardiomyopathy. The pacemaker system continually monitors to determine when a delivered pace pulse results in a fusion beat, and periodically adjusts the AV escape interval in accordance with the percentage or rate of incidence of such fusion beats. In one specific embodiment, the pacing system determines the percentage of delivered ventricular pace pulses which are followed by fusion beats over a predetermined number of intervals, and decrements AV escape interval when such percentage is not below a predetermined minimum. The pacing system also periodically increments AV escape interval when the rate of fusion beats is acceptable, thereby providing a closed loop system for maintaining the AV interval at an optimally long value consistent with maximizing full capture by delivered ventricular pace pulses. In another embodiment, the V--V escape interval of a non-tracking mode pacemaker is controlled to optimize pre-excitation of the ventricle.

    摘要翻译: 提供了一种双室起搏器,具有调整AV逃逸间隔的能力,从而优化用于治疗心肌病患者的输送心室起搏脉冲的时间。 起搏器系统持续监测以确定何时传送的步态脉冲导致融合节拍,并且根据这种融合节拍的百分比或发生率周期性地调整AV逃逸间隔。 在一个具体实施例中,起搏系统确定所提供的心室起搏脉冲的百分比,随后在预定数量的间隔上进行融合搏动,并且当该百分比不低于预定最小值时减小AV逃逸间隔。 当融合搏动速率可接受时,起搏系统还周期性地增加AV逃逸间隔,从而提供闭环系统,用于将AV间隔保持在最佳长度值,与通过传递的心室起搏脉冲最大化完全捕获相一致。 在另一个实施例中,控制非跟踪模式起搏器的V-V逃逸间隔以优化心室的预激发。

    Device and method for providing atrial-synchronized ventricular pacing with selective atrial tracking
    22.
    发明授权
    Device and method for providing atrial-synchronized ventricular pacing with selective atrial tracking 有权
    用于提供心房同步心室起搏和选择性心房跟踪的装置和方法

    公开(公告)号:US08332030B2

    公开(公告)日:2012-12-11

    申请号:US11115597

    申请日:2005-04-27

    IPC分类号: A61N1/00

    摘要: A device for delivering pacing therapy includes an atrial and ventricular leads, sensing circuitry connected to the leads for detecting depolarizations, and pulse generation circuitry for delivering ventricular pacing pulses based on sensed atrial depolarizations. The device includes control circuitry for controlling the pulse generation circuitry in a first mode in which the pulse generation circuitry delivers atrial synchronized pulses to both the right and left ventricular leads in response to each atrial depolarization sensed. In response to a detected atrial arrhythmia, the control circuitry causes the pulse generation circuitry to deliver atrial synchronized ventricular pacing pulses in response only to selected atrial depolarizations.

    摘要翻译: 用于输送起搏治疗的装置包括心房和心室引线,连接到用于检测去极化的引线的感测电路以及用于基于感测的心房去极化来输送心室起搏脉冲的脉冲产生电路。 该装置包括用于在第一模式中控制脉冲发生电路的控制电路,其中脉冲发生电路响应于感测到的每个心房去极化而将心房同步脉冲输送到右心室和左心室引线。 响应于检测到的心房心律失常,控制电路使得脉冲发生电路仅响应于所选择的心房去极化来递送心房同步心室起搏脉冲。

    Delivery of CRT therapy during AT/AF termination
    23.
    发明授权
    Delivery of CRT therapy during AT/AF termination 有权
    在AT / AF终止期间交付CRT治疗

    公开(公告)号:US07515959B2

    公开(公告)日:2009-04-07

    申请号:US11096511

    申请日:2005-03-31

    申请人: Michael F. Hess

    发明人: Michael F. Hess

    IPC分类号: A61N1/362

    摘要: In some embodiments, a method for operating a cardiac rhythm management device may include one or more of the following steps: (a) sensing atrial depolarizations through an implanted atrial electrode, (b) administering a sequential CRT pacing therapy in a sequential CRT pacing mode to a left and right ventricle of a heart of a patient via implanted ventricular electrodes in a sequential bi-ventricular fashion, (c) switching from the sequential CRT pacing mode to a simultaneous CRT pacing mode, (d) administering a simultaneous CRT pacing therapy in the simultaneous CRT pacing mode to the left and right ventricle in a simultaneous bi-ventricular fashion, (e) analyzing the sensed atrial depolarizations to detect the presence of an atrial arrhythmia, (f) analyzing the sensed atrial depolarizations while in the sequential CRT pacing mode to detect the presence of atrial arrhythmia, and (g) sensing ventricular depolarizations of the left and the right ventricle.

    摘要翻译: 在一些实施例中,用于操作心律管理装置的方法可以包括以下步骤中的一个或多个:(a)通过植入的心房电极感测心房去极化,(b)以连续的CRT起搏模式施用连续的CRT起搏治疗 (c)从连续的CRT起搏模式切换到同步的CRT起搏模式,(d)同时进行CRT起搏治疗,其中, (e)分析感测到的心房去极化以检测心房心律失常的存在,(f)分析感染的心房去极化,同时在顺序CRT中 起搏模式来检测心律失常的存在,(g)感测左心室和右心室的心室去极化。

    Mechanical Ventricular Pacing Non-Capture Detection for a Refractory Period Stimulation (RPS) Pacing Therapy Using at Least One Lead-Based Accelerometer
    24.
    发明申请
    Mechanical Ventricular Pacing Non-Capture Detection for a Refractory Period Stimulation (RPS) Pacing Therapy Using at Least One Lead-Based Accelerometer 有权
    机械心室起搏非捕获检测用于使用至少一个铅基加速度计的耐火期刺激(RPS)起搏治疗

    公开(公告)号:US20080269825A1

    公开(公告)日:2008-10-30

    申请号:US11742210

    申请日:2007-04-30

    IPC分类号: A61N1/37

    CPC分类号: A61N1/3627 A61N1/3712

    摘要: A system and method for monitoring at least one chamber of a heart (e.g., a left ventricular chamber) during delivery of a refractory period stimulation (RPS) therapy to determine if the desired non-capture (i.e., lack of ventricular mechanical capture due to refractory period stimulation) occurs. The system includes an implantable or external cardiac stimulation device in association with a set of leads such as epicardial, endocardial, and/or coronary sinus leads equipped with motion sensor(s). The device receives and processes acceleration sensor signals to determine a signal characteristic indicative of chamber capture due to pacing stimulus delivery, non-capture due to RPS therapy delivery, and/or contractile status based on the qualities of evoked response to pacing stimulation.

    摘要翻译: 一种用于在递送不期期刺激(RPS)治疗期间监测心脏(例如,左心室)的至少一个腔室的系统和方法,以确定是否期望的非捕获(即,由于缺乏心室机械捕获 难治期刺激)发生。 该系统包括与一组引线相关联的可植入或外部心脏刺激装置,例如配备有运动传感器的心外膜,心内膜和/或冠状窦导联。 该装置接收并处理加速度传感器信号以确定指示由于起搏刺激递送,由于RPS治疗递送而导致的非捕获和/或基于对起搏刺激的诱发响应的质量的收缩状态的室捕获的信号特征。

    Adaptive search AV and auto PVARP adaptation to same with additional
benefit
    25.
    发明授权
    Adaptive search AV and auto PVARP adaptation to same with additional benefit 失效
    自适应搜索AV和自动PVARP适应相同,具有额外的好处

    公开(公告)号:US5861007A

    公开(公告)日:1999-01-19

    申请号:US806302

    申请日:1997-02-26

    IPC分类号: A61N1/368 A61N1/362

    CPC分类号: A61N1/3627 A61N1/3682

    摘要: An AV search method and apparatus is taught with some variation described. It allows a pacemaker to find the appropriate AV interval so as to avoid pacing in the ventricle when it is not necessary, even if there is intermittent AV conduction in the patient. Also, an adaptive PVARP method and apparatus is disclosed that allows the PVARP and AV interval to be adjusted together automatically.

    摘要翻译: 教导具有一些变化的AV搜索方法和装置。 它允许起搏器找到适当的AV间隔,以避免在不必要的情况下在心室起搏,即使在患者中存在间歇性AV传导。 此外,公开了一种自适应PVARP方法和装置,其允许PVARP和AV间隔自动调整。

    Pacemaker with vasovagal syncope detection and therapy
    26.
    发明授权
    Pacemaker with vasovagal syncope detection and therapy 失效
    起搏器与血管迷走性晕厥检测和治疗

    公开(公告)号:US5501701A

    公开(公告)日:1996-03-26

    申请号:US309285

    申请日:1994-09-20

    IPC分类号: A61N1/365 A61N1/36

    CPC分类号: A61N1/365 A61N1/36514

    摘要: A method and apparatus for cardiac pacing, in which pacing pulses are provided at an increased rate in response to a detected rapid drop in heart rate. A rapid drop is detected in response to heart rate falling from a persistent rate above a first threshold rate to a stable rate below a second threshold rate. If spontaneous depolarizations are detected while pacing at the increased rate, pacing at the increased rate is terminated.

    摘要翻译: 用于心脏起搏的方法和装置,其中响应于检测到的心率快速下降以增加的速率提供起搏脉冲。 响应于心率从高于第一阈值速率的持续速率下降到低于第二阈值速率的稳定速率,检测到快速下降。 如果在以增加的速率起搏时检测到自发去极化,则以增加的速率起搏起止。

    Pacemaker with vasovagal syncope detection
    27.
    发明授权
    Pacemaker with vasovagal syncope detection 失效
    起搏器与血管迷走性晕厥检测

    公开(公告)号:US5441525A

    公开(公告)日:1995-08-15

    申请号:US246903

    申请日:1994-05-20

    IPC分类号: A61N1/365 A61N1/36

    CPC分类号: A61N1/36514 A61N1/365

    摘要: A rate-responsive cardiac pacemaker implements a novel scheme which detects incipient vasovagal syncope (or other episodes caused by a vasodepressive or cardioinhibitory disorder) when a) the heart rate drops below a programmable minimum size, and b) the rate after said drop is below a programmable maximum drop ending rate. The pacemaker implements a stability and intervention procedure upon the detection of an episode, in which it ignores transient drops in rate, and paces at a predetermined high rate if the drops are stable. The pacemaker then gradually reduces the pacing rate over a predetermined time to the pre-episodic level. A sleep disable feature disables the vasovagal syncope detection and therapy features during the patient's sleeping hours to reduce or eliminate false positive responses.

    摘要翻译: 速率响应心脏起搏器实施一种新颖的方案,其检测初期的血管迷走性晕厥(或由血管抑郁或心脏抑制障碍引起的其他发作),当a)心率下降到可编程的最小尺寸以下时,b)所述下降之后的速率低于 可编程的最大下降结束率。 起搏器在检测到发作时实现稳定性和干预程序,其中它忽略了速率的瞬时下降,并且如果液滴是稳定的,起搏器以预定的高速度步进。 然后,起搏器逐渐将起搏速度在预定时间内降低到事件发生前的水平。 睡眠禁用功能在患者睡眠时间内禁用血管迷走性晕厥检测和治疗功能,以减少或消除假阳性反应。

    Mechanical ventricular pacing capture detection for a post extrasystolic potentiation (PESP) pacing therapy using at least one lead-based accelerometer
    28.
    发明授权
    Mechanical ventricular pacing capture detection for a post extrasystolic potentiation (PESP) pacing therapy using at least one lead-based accelerometer 有权
    使用至少一个基于铅的加速度计进行后收缩期增强(PESP)起搏治疗的机械性心室起搏捕获检测

    公开(公告)号:US08738131B2

    公开(公告)日:2014-05-27

    申请号:US11688515

    申请日:2007-03-20

    IPC分类号: A61N1/365

    CPC分类号: A61N1/3712 A61N1/3627

    摘要: A system and method for monitoring at least one chamber of a heart (e.g., a left ventricular chamber) during delivery of extrasystolic stimulation to determine if the desired extra-systole (i.e., ventricular mechanical capture following refractory period expiration) occurs. The system includes an implantable or external cardiac stimulation device in association with a set of leads such as epicardial, endocardial, and/or coronary sinus leads equipped with motion sensor(s). The device receives and processes acceleration sensor signals to determine a signal characteristic indicative of chamber capture resulting from one or more pacing stimulus delivered closely following expiration of the refractory period. A threshold optimization method optionally evaluates capture and at least one of: runs an iterative routine to establish or re-establish chamber capture for the PESP therapy, sets a logical flag relating to chamber capture status and stores parameter(s) relating to successful chamber capture for one or more subsequent cardiac cycles.

    摘要翻译: 用于在递送收缩期刺激期间监测心脏(例如,左心室)的至少一个室的系统和方法,以确定是否发生期望的收缩期(即,在不应期内期满后的心室机械捕获)。 该系统包括与一组引线相关联的可植入或外部心脏刺激装置,例如配备有运动传感器的心外膜,心内膜和/或冠状窦导联。 该装置接收和处理加速度传感器信号,以确定指示由不可逆期间期满后紧密递送的一个或多个起搏刺激产生的指示腔室捕获的信号特征。 阈值优化方法可选地评估捕获和至少一个:运行迭代程序以建立或重新建立用于PESP治疗的室捕获,设置与室捕获状态相关的逻辑标志并存储与成功室捕获有关的参数 用于一个或多个随后的心动周期。

    MECHANICAL VENTRICULAR PACING CAPTURE DETECTION FOR A POST EXTRASYSTOLIC POTENTIATION (PESP) PACING THERAPY USING AT LEAST ONE LEAD-BASED ACCELEROMETER
    29.
    发明申请
    MECHANICAL VENTRICULAR PACING CAPTURE DETECTION FOR A POST EXTRASYSTOLIC POTENTIATION (PESP) PACING THERAPY USING AT LEAST ONE LEAD-BASED ACCELEROMETER 有权
    用于一个基于铅的加速度计的后处理电位(PESP)PACING治疗的机械性静脉瓣吸收检测

    公开(公告)号:US20080234771A1

    公开(公告)日:2008-09-25

    申请号:US11688515

    申请日:2007-03-20

    IPC分类号: A61N1/365 A61B5/02

    CPC分类号: A61N1/3712 A61N1/3627

    摘要: A system and method for monitoring at least one chamber of a heart (e.g., a left ventricular chamber) during delivery of extrasystolic stimulation to determine if the desired extra-systole (i.e., ventricular mechanical capture following refractory period expiration) occurs. The system includes an implantable or external cardiac stimulation device in association with a set of leads such as epicardial, endocardial, and/or coronary sinus leads equipped with motion sensor(s). The device receives and processes acceleration sensor signals to determine a signal characteristic indicative of chamber capture resulting from one or more pacing stimulus delivered closely following expiration of the refractory period. A threshold optimization method optionally evaluates capture and at least one of: runs an iterative routine to establish or re-establish chamber capture for the PESP therapy, sets a logical flag relating to chamber capture status and stores parameter(s) relating to successful chamber capture for one or more subsequent cardiac cycles.

    摘要翻译: 用于在递送收缩期刺激期间监测心脏(例如,左心室)的至少一个室的系统和方法,以确定是否发生期望的收缩期(即,在不应期内期满后的心室机械捕获)。 该系统包括与一组引线相关联的可植入或外部心脏刺激装置,例如配备有运动传感器的心外膜,心内膜和/或冠状窦导联。 该装置接收和处理加速度传感器信号,以确定指示由不可逆期间期满后紧密递送的一个或多个起搏刺激产生的指示腔室捕获的信号特征。 阈值优化方法可选地评估捕获和至少一个:运行迭代程序以建立或重新建立用于PESP治疗的室捕获,设置与室捕获状态相关的逻辑标志并存储与成功室捕获有关的参数 用于一个或多个随后的心动周期。

    Configurable cardioversion and defibrillation therapies in the presence of coexisting atrial and ventricular arrhythmia
    30.
    发明授权
    Configurable cardioversion and defibrillation therapies in the presence of coexisting atrial and ventricular arrhythmia 有权
    在存在共存心房和室性心律失常的情况下可配置的心脏复律和除颤疗法

    公开(公告)号:US07313436B2

    公开(公告)日:2007-12-25

    申请号:US10426495

    申请日:2003-04-30

    申请人: Michael F. Hess

    发明人: Michael F. Hess

    IPC分类号: A61N1/39

    摘要: An implantable cardioverter defibrillator system and method are provided having configurable shock therapies selected based on an evaluation of the atrial rhythm status following a ventricular tachycardia or fibrillation detection. A dual chamber shock configuration is selected if the ventricular arrhythmia is co-existing with an atrial arrhythmia of recent onset. A ventricular only shock configuration is selected if the ventricular arrhythmia is co-existing with a sustained atrial arrhythmia.

    摘要翻译: 提供了一种植入式心律转复除颤器系统和方法,其具有基于在室性心动过速或原纤维化检测之后的心房节律状态的评估来选择的可配置的休克疗法。 如果室性心律失常与近期发作的心房心律失常共存,则选择双室休克配置。 如果室性心律失常与持续的心房心律失常共存,则选择心室唯一的休克配置。